Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 5NIH 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 2Thoracic 1Plasma cell 1Head & Neck 1Genitourinary 1Gastrointestinal 1Classical hematology 1Breast 1

Conditions

Prostatic Neoplasms 134Urinary Bladder Neoplasms 47Kidney Neoplasms 38Carcinoma, Renal Cell 30Wilms Tumor 29Testicular Neoplasms 21Urethral Neoplasms 16Ovarian Neoplasms 15Neoplasm Metastasis 14Breast Neoplasms 14Neuroblastoma 12Sarcoma 11Teratoma 10Carcinoma, Non-Small-Cell Lung 9Testicular Germ Cell Tumor 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Ovarian Germ Cell Cancer 8Lung Neoplasms 8Endodermal Sinus Tumor 8Colorectal Neoplasms 7Burkitt Lymphoma 7Seminoma 6Osteosarcoma 6Neoplasms 6Colonic Neoplasms 6Carcinoma, Ovarian Epithelial 6Teratoma, Testicular 5Recurrence 5Pain 5Head and Neck Neoplasms 5

Interventions

Etoposide 1Cisplatin 1Bleomycin 1Amifostine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Drug-Related Side Effects and Adverse Reactions × Genitourinary × Clear all
NCT00003811 2013-07-04

Combination Chemotherapy Plus Amifostine in Treating Children With Malignant Germ Cell Tumors

Children's Oncology Group

Phase 2 Completed
27 enrolled
GenitourinaryGynecologic

Ovarian Germ Cell Cancer, Ovarian Neoplasms, Teratoma, Testicular Neoplasms, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡